Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

Optimising health after early menopause
Gita D. Mishra, Melanie Davies, Sarah Hillman, et al.
The Lancet (2024) Vol. 403, Iss. 10430, pp. 958-968
Closed Access | Times Cited: 25
Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
Ιrene Lambrinoudaki, Eleni Armeni, Dimitrios G. Goulis, et al.
Maturitas (2022) Vol. 163, pp. 1-14
Closed Access | Times Cited: 61
The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement
Margaret Rees, Kathy Abernethy, Gloria Bachmann, et al.
Maturitas (2022) Vol. 158, pp. 70-77
Open Access | Times Cited: 54
Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause
Nicole E. Cieri‐Hutcherson, Elaine K. Marji, Timothy C. Hutcherson
Menopause The Journal of The North American Menopause Society (2024) Vol. 31, Iss. 4, pp. 342-354
Closed Access | Times Cited: 10
Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
Ahmed A. Abo Elnaga, Mohamed A. Alsaied, Abdelrahman M. Elettreby, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2024) Vol. 297, pp. 142-152
Closed Access | Times Cited: 6
Hormonal Therapies in Multiple Sclerosis: a Review of Clinical Data
Stephanie Hsu, Riley Bove
Current Neurology and Neuroscience Reports (2023) Vol. 24, Iss. 1, pp. 1-15
Open Access | Times Cited: 14
Efficacy and safety of elinzanetant in vasomotor symptoms associated with menopause: A meta-analysis of randomized controlled trials
Milene Vitória Sampaio Sobral, Paula Melani Rocha, Leonardo Rodrigues, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2025)
Closed Access
Management of Menopause Symptoms
Julia Snyder, Coral Matus, E. M. Landis, et al.
Primary Care Clinics in Office Practice (2025)
Closed Access
Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy
Fatima Hassan, Anam Saleem, Sehar Saba Samuel, et al.
Medicine (2023) Vol. 102, Iss. 23, pp. e33978-e33978
Open Access | Times Cited: 9
Effects of menopause on temperature regulation
Marie Gombert, Kristine Vesterdorf, Andrea Fuller, et al.
Temperature (2025), pp. 1-41
Open Access
Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy
Meijun Pan, Jing Zhou, Xinyao Pan, et al.
Life Sciences (2022) Vol. 312, pp. 121255-121255
Closed Access | Times Cited: 15
Efficacy and safety of fezolinetant, a neurokinin-3 antagonist, in treating vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
Ummi Aiman Rahman, Talha Bin Kashif, Muhammad Usman, et al.
Medicine (2023) Vol. 102, Iss. 50, pp. e36592-e36592
Open Access | Times Cited: 9
Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
Melissa Conklin, Nanette Santoro
Therapeutic Advances in Reproductive Health (2023) Vol. 17
Open Access | Times Cited: 8
Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms, an appraisal
Anne Gompel, Cynthia A. Stuenkel
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101076-101076
Open Access | Times Cited: 7
FDA approved fezolinetant (Veozah): a critical evaluation of its efficacy and safety for menopausal vasomotor symptoms, calling for prospective research
Priya Rani, Dua Zehra, Malaika Mansoor, et al.
Archives of Women s Mental Health (2024) Vol. 27, Iss. 6, pp. 943-946
Closed Access | Times Cited: 1
NK3R antagonists: a novel approach for menopause symptoms
Simone Elder, Nanette Santoro
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 11, pp. 617-618
Closed Access | Times Cited: 3
Female Infertility Is Associated with an Altered Expression Profile of Different Members of the Tachykinin Family in Human Granulosa Cells
Víctor Manuel Vargas Blasco, Francisco M. Pinto, Ainhoa Fernández‐Atutxa, et al.
Reproductive Sciences (2022) Vol. 30, Iss. 1, pp. 258-269
Closed Access | Times Cited: 5
A Neuroendocrine Approach to Treat Menopausal Vasomotor Symptoms: A Brief Clinical Overview
Daisy G. Mullassery, Rebecca Tsusaki, Padmavathy Ramaswamy
The Journal for Nurse Practitioners (2023) Vol. 19, Iss. 10, pp. 104801-104801
Closed Access | Times Cited: 2
The management of vasomotor symptoms of menopause (VMS) with menopausal hormone therapy (MHT)
Tobias De Villiers
Current Opinion in Endocrine and Metabolic Research (2022) Vol. 27, pp. 100420-100420
Closed Access | Times Cited: 3
Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use
Hannah A. Blair
Drugs & Therapy Perspectives (2024) Vol. 40, Iss. 5, pp. 173-180
Closed Access
Integrative Lifestyle Considerations for Women in the Menopause Transition
M. Molinari, Gina B. Gonzalez, Kristi M. King
ACSMʼs Health & Fitness Journal (2024) Vol. 28, Iss. 4, pp. 74-79
Closed Access
Non-hormonal options for managing menopause symptoms: a narrative review
R. Alfonso, Gianluca Raffaello Damiani, Ilaria Romano, et al.
Italian Journal of Gynaecology and Obstetrics (2024), Iss. online first
Open Access
Neurokinin receptor antagonists as potential nonhormone treatments for vasomotor symptoms
Nanette Santoro
Menopause The Journal of The North American Menopause Society (2024) Vol. 31, Iss. 10, pp. 923-925
Closed Access
Are neurokinin 3 receptor antagonists effective in treatment of menopausal vasomotor symptoms?
Kathryn K. Garner, Luigi Olivieri
Evidence-Based Practice (2024)
Closed Access
Non-hormonal treatments of menopausal symptoms
Rehana Jan, Angus Rosie
InnovAiT Education and inspiration for general practice (2023) Vol. 16, Iss. 3, pp. 140-143
Closed Access
Page 1 - Next Page

Scroll to top